Marinus Pharmaceuticals, Inc. (MRNS)
NASDAQ: MRNS · Real-Time Price · USD
0.309
+0.002 (0.49%)
At close: Nov 20, 2024, 4:00 PM
0.301
-0.008 (-2.46%)
Pre-market: Nov 21, 2024, 6:56 AM EST
Marinus Pharmaceuticals Employees
As of December 31, 2023, Marinus Pharmaceuticals had 166 total employees, including 165 full-time and 1 part-time employees. The number of employees increased by 13 or 8.50% compared to the previous year.
Employees
166
Change (1Y)
13
Growth (1Y)
8.50%
Revenue / Employee
$189,554
Profits / Employee
-$846,331
Market Cap
17.02M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Meihua International Medical Technologies | 617 |
Retractable Technologies | 151 |
Cara Therapeutics | 55 |
Nephros | 31 |
Palatin Technologies | 30 |
Cognition Therapeutics | 28 |
Akari Therapeutics, | 12 |
Bullfrog AI | 11 |
MRNS News
- 8 days ago - Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results - Business Wire
- 4 weeks ago - Marinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic Alternatives - Business Wire
- 5 weeks ago - Marinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual Meeting - Business Wire
- 5 weeks ago - 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity - Benzinga
- 5 weeks ago - Marinus Pharmaceuticals Further Strengthens Intellectual Property Estate with Method of Treatment Patent for ZTALMY® Titration Regimens - Business Wire
- 6 weeks ago - Marinus Pharmaceuticals Announces Podium and Poster Presentations at the Neurocritical Care Society 2024 Annual Meeting - Business Wire
- 6 weeks ago - Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire
- 6 weeks ago - Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech? - Benzinga